China Pharma Holdings (CPHI) Capital Expenditures (QoQ) (2010 - 2025)
China Pharma Holdings (CPHI) Capital Expenditures (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | China Pharma Holdings | 41.38 Mn | 41.08 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -25.70% |
| Sep 30, 2025 | 1,040.00% |
| Jun 30, 2025 | -100.11% |
| Mar 31, 2025 | 198.41% |
| Dec 31, 2024 | 311.98% |
| Dec 31, 2023 | -93.29% |
| Sep 30, 2023 | 1,598.67% |
| Jun 30, 2023 | 91.96% |
| Mar 31, 2023 | -105.24% |
| Dec 31, 2022 | -110.80% |
| Sep 30, 2022 | 44.07% |
| Jun 30, 2022 | 12,501.80% |
| Mar 31, 2022 | -80.29% |
| Dec 31, 2021 | -98.30% |
| Dec 31, 2020 | -189.65% |
| Sep 30, 2020 | -47.34% |
| Jun 30, 2020 | 41.65% |
| Mar 31, 2020 | 591.94% |
| Dec 31, 2019 | 311.97% |
| Sep 30, 2019 | 3,819.82% |